Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.
Clinical trial NCT05276492 · TERMINATED
Trial details
- NCT number
- NCT05276492
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-24
- Primary completion
- 2024-11-16
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.